http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109021068-B

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-08
filingDate 2018-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2020-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2020-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-109021068-B
titleOfInvention Linear pseudo-polypeptide, preparation method thereof and application thereof in antibacterial drugs
abstract The invention discloses a linear pseudopolypeptide, a preparation method thereof and application thereof in antibacterial drugs. The linear pseudopolypeptide comprises biological isoelectroforms of Loloatin C pharmacore sequence structure, namely biological isoelectroforms comprising Tyr, Pro, Trp and Phe, and four amino acid residues are in L-configuration or D-configuration, so that the linear pseudopolypeptide has more stable structure and higher stability in plasma. The linear pseudopolypeptide is prepared by a solid-phase synthesis method, and the total yield is 25-35%. The preparation method of the linear pseudo polypeptide has the advantages of mild reaction conditions, easy automation, simple and safe operation, high product purity and high total yield, and the prepared linear polypeptide can be used for preparing antibacterial drugs, particularly drugs for treating gram-positive bacteria or gram-negative bacteria infection, and has the advantages of high efficiency, broad spectrum and difficult generation of drug resistance.
priorityDate 2018-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID423492199
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45485349
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419547992
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453330028
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2724699
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457585837
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419487744
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12052
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426283276
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID978332
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448212190
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71567
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397441
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23501187
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414869995
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54438848
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71080
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1049
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16139121
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396490
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419540685
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416106034
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559037
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6347578
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408494874

Total number of triples: 41.